Navigation Links
Khosla Phaco System

ProductsKhosla Phaco System
Company Khosla Medical & Surgical, Inc.
Item Khosla Phaco System
Features 
  • Feature Packed And Easy To Use
  • All Titanium U/S Handpiece
  • Advanced Irrigation And Aspiration
  • Continuously Autotuned Emulsification
  • Built In Vitrectomy And Cautery
  • Convenient, Travel Tested Portability
  • Superior Components Provide Excellent Reliability
  • Truly Affordable
  • FDA Approved & Made In USA
  • Description New!
    Info Khosla Medical & Surgical, Inc.
    Customer Service: (408) 996 0205
    Web site: http://www.khosla-med.com/

    Related medicine products :

    1. Khosla Mini Non-Illuminated Trial Lens Set, With Lenses Mounted
    2. Khosla Non-Illuminated Trial Lens Set, With Lenses Mounted
    3. Khosla Binocular Indirect Ophthalmoscope
    4. Khosla Irrigation/Aspiration Vitrectomy Unit
    5. Khosla Vitrectomy Super Deluxe
    6. Khosla Irrigation Aspiration Unit
    7. Khosla Vitrectomy Super (Gas Operated)
    8. Operating Microscope With Khosla Head
    9. Khosla Applanation Tonometer
    10. Khosla Slit Lamp Set
    11. Khosla Slit Lamp Imaging System
    ...e new Finnpipette Focus from Thermo Labsystems was...uncompromising performance. Advanced features suc...me adjustment on microvolumes help to define this ...w interchangeable handle plate offers a custom fit...
    ...e Eppendorf Reference Series 2000 Pipette is a syn...mpact and robust design, and superior operating co...to operate the measuring stroke and blow-out as we... "pipette/tip" system ensures utmost accuracy and ...
    ...e Integrity family of pacemakers features several ...n today's worldwide pacing market. Offering an unp...agnostic information, the system builds on the pop... ,It incorporates the exclusive ventricular Auto...
    ...e Identity pacemaker family, which includes the wo...inicians with the most advanced pacemaker technolo...ession algorithm, the first and only U.S. commerci...l fibrillation (AF). The AF Suppression algorithm ...
    Medicine Products:
    (Date:11/24/2009)...24/PRNewswire-FirstCall/-HardtoTreatDiseases(HTDS;...diarySlavicaBioChem,isprovidingthisbriefupdatetoit...uediligencewiththeEUstemcellcompanyandmergerdiscus...tOct29,2009whichthecompanymade. http://www.pinkshe... ,, HTDSandSlavicaBiochemarealsodiscussingonexp...
    (Date:11/24/2009)...swire-USNewswire/--Thereisanewgameintownwhenitcome...feringpragmaticandrealisticstrategieswheretraditio...ingthismovementisagroupcalledHAMS--HarmReduction,A...f-charge,lay-ledsupportandinformationalgroupforpeo...coholAbuseandAlcoholismtellsusthatonly7%ofpeoplewi...
    (Date:11/24/2009)...swire/--TheGuardianLifeInsuranceCompanyofAmerica(G...ingproviderofemployeebenefitsforsmallandmid-sizedc...ofollowitscurrentinsurancecoverageguidelinesformam...htheAmericanCancerSocietyandAmericanMedicalAssocia...,, Recently,TheU.S.PreventiveServicesTaskForcer...
    (Date:11/24/2009)...USPSTFRepresentationandRecommendationProcess ,...alsectionsofSenatehealthcarereformlegislation cont...rivateinsurers,MedicareandMedicaidwouldonlyberequi...S.PreventativeServicesTaskForce.Presently,thiswoul...requirecoverageofbiennial(everyotheryear)coveragef...
    (Date:11/24/2009)...r 24, 2009 Researchers at Ben-Gurion University o...ts cancerous skin tumors, including melanomas that...al testing, the OSPI instrument (Optical Spectro-P...ons that have never been seen before - including m...s skin lesions and were awaiting surgery for their...
    Breaking Medicine News(10 mins):Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 2Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 3Health News:Harm Reduction for Alcohol: An Idea Whose Time Has Arrived 2Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 2Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 3Health News:New device enables early detection of cancerous skin tumors -- Ben Gurion U. 2
    ...you to cast a ballot, study suggests , , T...polls on Nov. 4? If so, your genes may be driving...ch as 50 percent of whether you vote or not may be...an family political history. , "Both nature and nu...
    ...The following is a,statement by Christine James-Br...hat Congress has taken the authority and opportuni...nd Targeted Case Management,(TCM) rules, as well a...d and clear statement that it is wrong to,target t...
    ...frastructure Helps Spanish Health Administrator, ...ngoing IT Development ...Inc.,(Nasdaq: TIBX ) today announced that the hea...alud (SERIS) will link,together a range of applica...
    ... ETHICON, Inc., a Johnson &,Johnson company, toda...tional offer from One Equity Partners to acquire t...cted a competitive bidding process to,prepare for ...One Equity Partners. The Professional Wound Care b...
    ... The Compassionate Friends self-help support org...rieving process following the death of a child is ... Nashville, Tennessee. More than 1300 parents, sib...more than 100 workshops covering most aspects of g...
    ... Professional Services, Information Security and ...Class Framework, DALLAS, July 1 The Health Infor...at it is on target to deliver the first-ever,Commo...curity specialists, liability insurers and other,o...
    Other Medicine News:Health News:Genes Get Out the Vote 2Health News:Genes Get Out the Vote 3Health News:Statement by Christine James-Brown, President and CEO, Child Welfare League of America (CWLA) Re: Moratorium on Medicaid Regulations 2Health News:Rioja Hospital Uses TIBCO Software to Improve Customer Care and Streamline Operations 2Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 2Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 3Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 4Health News:Families Mourning Children Travel to Nashville for July Compassionate Friends National Conference 2Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 2Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 3Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 4Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 5
    (Date:11/24/2009)..., XI,AN,China,Nov.24/PRNewswire-Asia/--HuifengBi...HFGB),aleadingdeveloperandproducer,ofplantextracts...l,nutraceuticalandfoodproductioninXi,an,China,tod...da26%increaseinrevenues. , Revenuesforthequar...31,147,or26%,from$3,534,623forthesamequarterin2008...
    (Date:11/24/2009)..., NORTHHOLLYWOOD,Calif.,Nov.24/PRNewswire-FirstC...,aleadingnationalhospitalistphysiciangrouppractice...anIPChospitalist,wasnamedby ACPHospitalist asoneof...edintheNovember2009issueofthemagazine. ,, Dr.Va...andcurrentlyservesasdirectorofhospitalmedicineatSt...
    (Date:11/24/2009)..., WARSAW,Ind.,Nov.24/PRNewswire-FirstCall/--Zimm...twillbeparticipatinginthe21stAnnualPiperJaffrayHea...9,at8:00a.m.EasternTime. ,, Alivewebcastofthepr...swebsiteat http://investor.zimmer.com .Thewebcastw..., AbouttheCompany ,, Foundedin1927andheadquar...
    Breaking Medicine Technology:Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2BioWa and NKTT Announce Licensing of BioWas POTELLIGENT 28R 29 Technology For Use in Antibody Research and Development 14560 1BioWa and NKTT Announce Licensing of BioWas POTELLIGENT 28R 29 Technology For Use in Antibody Research and Development 14560 2BioWa and NKTT Announce Licensing of BioWas POTELLIGENT 28R 29 Technology For Use in Antibody Research and Development 14560 3Gamida Cell and Cellerix Partner on Feasibility Study 14558 1Gamida Cell and Cellerix Partner on Feasibility Study 14558 2Gamida Cell and Cellerix Partner on Feasibility Study 14558 3Delcath Systems Inc Completes Phase III Study Enrollment 5635 1Delcath Systems Inc Completes Phase III Study Enrollment 5635 2Delcath Systems Inc Completes Phase III Study Enrollment 5635 3